| Members |
targetComponentId |
| Chlormethiazole edisylate 8mg/mL infusion |
Product containing clomethiazole (medicinal product) |
| Chlormethiazole edisylate 8mg/mL infusion |
Product containing clomethiazole (medicinal product) |
| Chlorofluorocarbon |
Freon |
| Chlorofluorocarbon |
Chlorofluorocarbon |
| Chloroform |
Chloroform |
| Chloroquine phosphate 80mg/5mL syrup |
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Chloroquine sulfate 68mg/5mL syrup |
Product containing precisely chloroquine sulfate 13.6 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Chlorpheniramine maleate 10mg/1mL injection |
Chlorphenamine maleate 10 mg/mL solution for injection |
| Chlorpheniramine maleate 2mg/5mL sugar free syrup |
Chlorphenamine maleate 400 microgram/mL oral solution |
| Chlorpheniramine maleate 2mg/5mL syrup |
Chlorphenamine maleate 400 microgram/mL oral solution |
| Chlorpromazine hydrochloride 100mg/5mL s/f oral solution |
Chlorpromazine hydrochloride 20 mg/mL oral solution |
| Chlorpromazine hydrochloride 100mg/5mL s/f suspension |
Chlorpromazine hydrochloride (as chlorpromazine embonate) 20 mg/mL oral suspension |
| Chlorpromazine hydrochloride 100mg/5mL syrup |
Chlorpromazine hydrochloride 20 mg/mL oral solution |
| Chlorpromazine hydrochloride 25mg injection solution 1mL vial |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Chlorpromazine hydrochloride 25mg/1mL injection |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Chlorpromazine hydrochloride 25mg/1mL injection |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Chlorpromazine hydrochloride 25mg/5mL s/f oral solution |
Chlorpromazine hydrochloride 5 mg/mL oral solution |
| Chlorpromazine hydrochloride 25mg/5mL syrup |
Chlorpromazine hydrochloride 5 mg/mL oral solution |
| Chlorpromazine hydrochloride 25mg/mL injection |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Chlorpromazine hydrochloride 25mg/mL injection solution 2mL ampule |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Chlorpromazine hydrochloride 50mg/2mL injection |
Product containing precisely chlorpromazine hydrochloride 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Choanotaenia species |
Choanotaenia |
| Choking |
Choking |
| Choking |
Choking sensation (finding) |
| Choking: [symptom] or [sensation] |
Choking sensation (finding) |
| Cholangiopancreatography catheter, reusable |
Cholangiopancreatography catheter (physical object) |
| Cholangiopancreatography catheter, single-use |
Cholangiopancreatography catheter (physical object) |
| Cholecalciferol or ergocalciferol |
Product containing ergocalciferol (medicinal product) |
| Cholecalciferol or ergocalciferol |
Product containing colecalciferol (medicinal product) |
| Cholecystectomy: [total NEC] or [NEC] |
Cholecystectomy |
| Cholecystoenterostomy |
Cholecystojejunostomy |
| Cholecystojejunostomy (& Roux en Y) |
Roux-en-Y cholecystojejunostomy |
| Cholecystojejunostomy (& Roux en Y) |
Cholecystojejunostomy |
| Cholecystokinin measurement |
Measurement of cholecystokinin in serum |
| Choledochoduodenostomy |
Choledochoduodenostomy |
| Choledochoduodenostomy |
Duodenocholedochotomy |
| Choledocholithotomy |
Choledochostomy with removal of calculus |
| Choledocholithotomy |
Choledocholithotomy (procedure) |
| Choledocholithotomy |
Bile duct stone removal (procedure) |
| Choledocholithotomy: [open NEC] or [NEC] |
Bile duct stone removal (procedure) |
| Cholelithiasis |
Calculus of bile duct |
| Cholelithiasis |
Gallstone |
| Cholelithiasis |
Calculus of cystic duct |
| Cholelithiasis |
Biliary calculus |
| Cholera contact |
Exposure to Vibrio cholerae (event) |
| Cholera contact |
Exposure to Vibrio cholerae (event) |
| Cholera vaccine |
Vibrio cholerae antigen-containing vaccine product |
| Cholera vaccine |
Vibrio cholerae antigen-containing vaccine product |
| Cholesteatoma &/or aural polyp |
Cholesteatoma of middle ear |
| Cholesteatoma &/or aural polyp |
Cholesteatoma and aural polyp |
| Cholesteatoma of middle ear AND/OR mastoid |
Cholesteatoma of middle ear and mastoid (disorder) |
| Cholesteatoma of middle ear and mastoid structure |
Cholesteatoma of middle ear and mastoid (disorder) |
| Cholesterol embolization syndrome |
Ischemic toe |
| Cholesterol embolization syndrome |
Cholesterol embolus syndrome |
| Cholesterol-related arthritis and periarthritis |
Secondary osteoarthritis (disorder) |
| Cholestyramine 4g/sachet powder sugar free |
Colestyramine 4 g powder for oral suspension sachet |
| Cholestyramine sug free powder 4g/sachet |
Colestyramine 4 g powder for oral suspension sachet |
| Cholestyramine sug free powder 4g/sachet |
Colestyramine 4 g powder for oral suspension sachet |
| Cholestyramine sugar free powder |
Colestyramine 4 g powder for oral suspension sachet |
| Cholinergic anaphylactoid reaction |
Non-allergic anaphylaxis caused by parasympathomimetic agent |
| Cholinergic anaphylactoid reaction |
Non-allergic anaphylaxis caused by organic phosphorous compound (disorder) |
| Cholinesterase genotype |
Butyrylcholinesterase genotype determination (procedure) |
| Cholinesterase genotype |
Butyrylcholinesterase genotype determination (procedure) |
| Cholinesterase genotype |
Butyrylcholinesterase genotype determination (procedure) |
| Cholinesterase genotype determination |
Butyrylcholinesterase genotype determination (procedure) |
| Cholinesterase inhibitor |
Acetylcholinesterase inhibitor (disposition) |
| Cholinesterase measurement |
Butyrylcholinesterase measurement (procedure) |
| Cholinesterase phenotype |
Butyrylcholinesterase phenotype determination (procedure) |
| Cholinesterase phenotype |
Butyrylcholinesterase phenotype determination (procedure) |
| Cholinesterase phenotype determination |
Butyrylcholinesterase phenotype determination (procedure) |
| Cholinesterase reactivator |
Acetylcholinesterase reactivator |
| Cholinesterase reactivator adverse reaction |
Acetylcholinesterase reactivator adverse reaction (disorder) |
| Cholinesterase screening test |
Butyrylcholinesterase screening test |
| Chondrocalcinosis due to dicalcium phosphate crystals, of the forearm |
Chondrocalcinosis due to dicalcium phosphate crystals |
| Chondrocalcinosis due to dicalcium phosphate crystals, of the lower leg |
Chondrocalcinosis due to dicalcium phosphate crystals |
| Chondrocalcinosis due to dicalcium phosphate crystals, of the upper arm |
Chondrocalcinosis due to dicalcium phosphate crystals, of the shoulder region |
| Chondrocalcinosis due to pyrophosphate crystals of: [lower leg] or [knee] |
Chondrocalcinosis due to pyrophosphate crystals of the knee |
| Chondrocalcinosis due to pyrophosphate crystals, of the forearm |
Chondrocalcinosis due to pyrophosphate crystals (disorder) |
| Chondrocalcinosis due to pyrophosphate crystals, of the lower leg |
Chondrocalcinosis due to pyrophosphate crystals of the knee |
| Chondrocalcinosis due to pyrophosphate crystals, of the upper arm |
Chondrocalcinosis due to pyrophosphate crystals, of the shoulder region |
| Chondrodysplasia punctata, Conradi-Hünermann type |
Chondrodysplasia punctata, X-linked dominant type (disorder) |
| Chondrodysplasia punctata, Conradi-Hünermann type |
Chondrodysplasia punctata, Conradi-Hünermann type (disorder) |
| Chondrodysplasia, otherwise specified |
Chondrodysplasia (disorder) |
| Chondrodystrophy malacia |
Degenerative disorder |
| Chondrodystrophy malacia |
Disorganized development of cartilaginous and fibrous components of the skeleton |
| Chorioallantoic placenta |
Anomaly of placenta (disorder) |
| Chorioamnionitis |
Infection of amniotic cavity |
| Chorioamnionitis |
Chorioamnionitis |
| Choriogonadotropin alfa 250micrograms injection solution 0.5mL prefilled syringe |
Product containing precisely choriogonadotropin alfa 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Choriogonadotropin measurement |
Human chorionic gonadotropin measurement |
| Chorionic gonadotropin, beta-subunit measurement |
Chorionic gonadotropin, beta-subunit measurement (procedure) |
| Chorionic gonadotropin, beta-subunit measurement |
Chorionic gonadotropin, beta-subunit measurement, spinal fluid (procedure) |
| Chorionic villus sampling - special tests |
Sampling of chorionic villus |
| Chorioptes species |
Chorioptes |
| Chorioretinal scar of posterior pole of bilateral eyes |
Chorioretinal scar of bilateral eyes (disorder) |
| Chorioretinal scar of posterior pole of bilateral eyes |
Bilateral scar of posterior pole of retinas |
| Chorioretinal scar of posterior pole of left eye |
Scar of posterior pole of retina of left eye |
| Chorioretinal scar of posterior pole of left eye |
Chorioretinal scar of left eye |
| Chorioretinal scar of posterior pole of right eye |
Chorioretinal scar of right eye |
| Chorioretinal scar of posterior pole of right eye |
Scar of posterior pole of retina of right eye |
| Chorioretinitis |
Chorioretinitis |
FHIR